MICHAEL O'CONNOR: Open Payments
NPI 1295468049 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 22 payments from 5 companies in 2025. Trend: 2023 $359 · 2024 $507 · 2025 $428
Food & beverage: $368Education: $60
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| GENZYME CORPORATION | 5 | $93 |
| Hikma Pharmaceuticals USA | 6 | $90 |
| Optinose US, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: DUPIXENT, Ryaltris, Xhance, NUCALA.
Industry payments across NJ — which companies pay providers there.
